{"id":"https://openalex.org/W2121001288","doi":"https://doi.org/10.1093/jac/26.suppl_e.87","title":"Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis","display_name":"Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis","alternate_titles":[],"publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W2121001288","doi":"https://doi.org/10.1093/jac/26.suppl_e.87","mag":"2121001288","pmid":"https://pubmed.ncbi.nlm.nih.gov/2127269"},"language":"en","primary_location":{"id":"doi:10.1093/jac/26.suppl_e.87","doi":"https://doi.org/10.1093/jac/26.suppl_e.87","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/26.suppl_e.87","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2121001288"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023628876","display_name":"Pierre G\u00e9hanno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Gehanno","raw_affiliation_strings":["H\u00f4pital Bichat, Paris, France","H\u00f4pital Bichat, 46 rue Henri Huchard75018 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Bichat, Paris, France","institution_ids":["https://openalex.org/I4210145170"]},{"raw_affiliation_string":"H\u00f4pital Bichat, 46 rue Henri Huchard75018 Paris, France","institution_ids":["https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109164937","display_name":"J Depondt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Depondt","raw_affiliation_strings":["H\u00f4pital Bichat, 46 rue Henri Huchard 75018 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Bichat, 46 rue Henri Huchard 75018 Paris, France","institution_ids":["https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042833484","display_name":"B. Barry","orcid":"https://orcid.org/0000-0002-5953-3982","observed_orcids":["https://orcid.org/0000-0002-5953-3982"]},"institutions":[{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Barry","raw_affiliation_strings":["H\u00f4pital Bichat, 46 rue Henri Huchard 75018 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Bichat, 46 rue Henri Huchard 75018 Paris, France","institution_ids":["https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109249731","display_name":"Michel Simonet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Simonet","raw_affiliation_strings":["H\u00f4pital Necker 149 rue de s\u00e9vres, 75015 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Necker 149 rue de s\u00e9vres, 75015 Paris, France","institution_ids":["https://openalex.org/I1288880153"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053245618","display_name":"H. Dewever","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154425","display_name":"Centre Hospitalier Universitaire de Saint-Pierre","ror":"https://ror.org/05cmp5q80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210154425"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Dewever","raw_affiliation_strings":["H\u00f4pital Universitaire Saint-Pierre Bruxelles, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Universitaire Saint-Pierre Bruxelles, Belgium","institution_ids":["https://openalex.org/I4210154425"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":4.8453,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.94835355,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"26","issue":"suppl E","first_page":"87","last_page":"91"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10984","display_name":"Sinusitis and nasal conditions","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10984","display_name":"Sinusitis and nasal conditions","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.09629999846220016,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12297","display_name":"Otolaryngology and Infectious Diseases","score":0.07999999821186066,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefpodoxime-proxetil","display_name":"cefpodoxime proxetil","score":1.0},{"id":"https://openalex.org/keywords/cefaclor","display_name":"cefaclor","score":1.0},{"id":"https://openalex.org/keywords/acute-rhinosinusitis","display_name":"acute sinusitis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.9110000133514404},{"id":"https://openalex.org/keywords/antibiotic-efficacy","display_name":"antibiotic efficacy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/clinical-cure","display_name":"clinical cure","score":0.5230000019073486},{"id":"https://openalex.org/keywords/bacteriological-response","display_name":"bacteriological response","score":0.7770000100135803},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.578000009059906},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C2779766023","wikidata":"https://www.wikidata.org/wiki/Q415167","display_name":"Cefaclor","level":4,"score":0.7465841770172119},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5444179773330688},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.5256344676017761},{"id":"https://openalex.org/C74916050","wikidata":"https://www.wikidata.org/wiki/Q841090","display_name":"Classics","level":1,"score":0.4607603847980499},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.3342498242855072},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.13956281542778015},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0871172547340393},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000097627","descriptor_name":"Cefpodoxime Proxetil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002433","descriptor_name":"Cefaclor","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002433","descriptor_name":"Cefaclor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005779","descriptor_name":"Immunodiffusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012852","descriptor_name":"Sinusitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012852","descriptor_name":"Sinusitis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D015296","descriptor_name":"Ceftizoxime","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015296","descriptor_name":"Ceftizoxime","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015296","descriptor_name":"Ceftizoxime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jac/26.suppl_e.87","doi":"https://doi.org/10.1093/jac/26.suppl_e.87","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/26.suppl_e.87","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:2127269","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2127269","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.856.8783","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.856.8783","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jac.oxfordjournals.org/content/26/suppl_E/87.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2019794250","https://openalex.org/W2915461924","https://openalex.org/W1970451646","https://openalex.org/W79635155","https://openalex.org/W2020386620","https://openalex.org/W2063908694","https://openalex.org/W89639332","https://openalex.org/W176139117"],"abstract_inverted_index":{"The":[0,61],"efficacy":[1,64],"and":[2,84],"tolerance":[3],"of":[4,11,31,46,51],"cefpodoxime":[5,33,81,100],"proxetil":[6,34,82,101],"were":[7],"compared":[8],"with":[9,74,95,106],"those":[10],"cefaclor":[12,56,89,107],"in":[13,21,44,54,70,79,87,98],"a":[14],"multicentre,":[15],"international,":[16],"prospective,":[17],"double-blind,":[18],"placebo-controlled":[19],"study":[20],"adult":[22],"outpatients":[23],"suffering":[24],"from":[25],"acute":[26],"sinusitis.":[27],"At":[28],"the":[29,55,71,80,88,99],"end":[30],"treatment,":[32],"was":[35,68,93],"more":[36],"effective":[37],"than":[38],"cefaclor,":[39],"producing":[40],"complete":[41],"clinical":[42,63],"cure":[43],"84%":[45],"cases":[47,52],"(102/122)":[48],"vs":[49,104],"68%":[50],"(77/114)":[53],"group":[57,83,102],"(P":[58],"=":[59],"0.01).":[60],"overall":[62],"(cure":[65],"+":[66],"improvement)":[67],"similar":[69,94],"two":[72],"groups":[73],"95%":[75,96],"(116/122)":[76],"satisfactory":[77],"responses":[78],"93%":[85],"(106/114)":[86],"group.":[90],"Bacteriological":[91],"response":[92],"eradication":[97],"(55/58)":[103],"91%":[105],"(63/69).":[108]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2121001288","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
